NRIX
NRIX P/E Ratio
P/E Ratio as of Oct 26, 2026: 11.05
Average2.40
Median9.57
Minimum-6.88
Maximum11.28
11.05
17.72 (265.67%)past month
The P/E ratio for NRIX is 11.05 as of Oct 26, 2026. This represents a decrease of -285.71% compared to its 12-month average P/E ratio of -5.95. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Nurix Therapeutics, Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Nurix Therapeutics, Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Nurix Therapeutics, Inc to industry peers.
Nurix Therapeutics, Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Nurix Therapeutics, Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Nurix Therapeutics, Inc to industry peers.
NRIX P/E Ratio Insights
See Nurix Therapeutics, Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NRIX
Order type
Buy in
Order amount
Est. shares
0 shares
NRIX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $23.34 | -6.77 |
| Sep 1, 2026 | $26.04 | -7.55 |
| Aug 3, 2026 | $23.22 | -6.74 |
| Jul 1, 2026 | $23.91 | -7.57 |
| Jun 1, 2026 | $17.39 | -5.50 |
| May 1, 2026 | $16.81 | -5.32 |
| Apr 1, 2026 | $15.48 | -5.09 |
| Mar 2, 2026 | $15.81 | -5.20 |
| Feb 2, 2026 | $17.09 | -5.62 |
| Jan 2, 2026 | $18.06 | -6.09 |
NRIX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 11.05 | -272.66% |
| 2025 | -6.40 | -1.08% |
| 2024 | -6.47 | +65.90% |
| 2023 | -3.90 | +32.20% |
| 2022 | -2.95 | -72.25% |
| 2021 | -10.63 | — |
FAQs About Nurix Therapeutics, Inc (NRIX) P/E ratio
The latest P/E ratio of NRIX is 11.05, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Nurix Therapeutics, Inc’s last 12-month average P/E ratio is -5.95, compared to its current P/E ratio of 11.05. This reflects a decrease of -285.71%.
Nurix Therapeutics, Inc’s current P/E ratio of 11.05 is lower than its last 12-month average P/E of -5.95. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Nurix Therapeutics, Inc’s average P/E ratio over the last 3 years is -5.45. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Nurix Therapeutics, Inc’s average P/E ratio over the last 5 years is -5.14. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
NRIX P/E Ratio Insights
See Nurix Therapeutics, Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NRIX
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.